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Background
ARTservices are expanding in Sub Saharan African
countries. In Rwanda the demographic and health sur-
v e yo f2 0 0 5 ( D H S )s h o w e dap r e v a l e n c er a t eo f3 % a t
national level and by the end of June 2009, 70234 per-
sons had initiated ARV at 217 sites in Rwanda (TRAC-
net report June 2009). Kimironko health center has
provided care and treatment to patients since 2003, at
this point there are 1776 patients followed in the HIV
clinic at this health center. It is important to evaluate
immunologic responses and efficacy of antiretroviral
therapy in resource poor settings.
Methods
We conducted a retrospective cohort study to assess
immunological outcomes among adult patients who
initiated ART from January 1, 2007 to December 31,
2008. 426 patients were eligible for the study and data
were analyzed using Epi info 3.2.2 and SPSS 17.
Results
The median age of our patients at ART initiation was 34
years and 66,9% were female. At ART initiation the
median baseline CD4+ cell count was 192 cells per
micro liter, the median CD4+ cell count increased by 90
cells per micro liter at 6 months(n = 393) [interquartile
range (IQR) 191-372] and 112 cells per micro liter [IQR
230-408] at 12 months(n = 266). Women had higher
median baseline CD4 cell counts than men (197 vs. 176/
μL). First-line ART regimens contained Lamivudine
(100%), Stavudine (68,3%), Zidovudine (31%), and either
Efavirenz (14%) or Nevirapine (85,7%).
Discussion
These data demonstrate robust and sustained CD4
response to ART among patients continuing on therapy.
Despite not having viral load testing, using CD4 criteria
alone indicates efficacy of first line therapies. Public
health and programmatic interventions leading to earlier
HIV diagnosis and initiation of ART could substantially
improve patient outcomes in resource-limited settings.
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